Mannheim: the bottleneck in child painkillers – regional economy

Author: Matthias Kros

Manheim. In Germany, pharmacies are currently struggling with problems with the supply of medicines for children. The Federal Institute for Medicines and Medical Devices (BfArM) confirms in a statement that juices for fever with the active ingredients ibuprofen and paracetamol are particularly lacking. Therefore, extensive research and testing has already been carried out. Subsequently, bottlenecks are mainly due to a supplier’s withdrawal. In addition, there is also the “distribution problem”. Finally, the demand for the drugs in question has increased disproportionately this year. The reasons for this have not yet been satisfactorily established.

In addition to the crown, various other infectious diseases are now on the rise in Germany. Fever is a common symptom in children. As they are usually not yet able to swallow tablets, juices and suppositories are considered to be the form of administration of the active ingredients which is particularly suitable for children. However, juices do not have as long a shelf life as tablets and are therefore not as cost effective for producers. Consequently, many have moved production to Asia, where a large proportion of the drugs have been stuck in ports for months due to a corona blockade.

The pharmaceutical wholesaler Phoenix in Mannheim is responsible for the distribution of drugs. The company describes itself as the “leading provider of integrated healthcare” and supplies around 60,000 pharmacies in Europe with nearly 40,000 employees. However, when asked about the RNZ, Phoenix himself declined to comment on the painkiller problem and instead referred to the Pharmaceutical Wholesalers Association (PHAGRO), to which the Mannheimers themselves belong. “Currently, it is indeed the case that pharmaceutical wholesalers cannot fully fulfill orders for juices containing paracetamol or ibuprofen,” said a spokeswoman for the association. The causes of supply bottlenecks vary from

Leave a Comment